Evidence map›Paper›PMID 29212472›Full record

ArticleBMC medical informatics and decision making2017

Autism risk classification using placental chorionic surface vascular network features.

Jen-Mei Chang, Hui Zeng, Ruxu Han, Ya-Mei Chang, Ruchit Shah, Carolyn M Salafia, Craig Newschaffer, Richard K Miller, Philip Katzman, Jack Moye and 3 more

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Placental Alterations in Autism Spectrum Disorder: An In Silico Approach to circRNA-miRNA-mRNA Networks.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2025
    Article
  3. Article
  4. Mechanisms of neurodevelopmental toxicity of topiramate.Critical reviews in toxicology · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jen-Mei ChangDepartment of Mathematics and Statistics, California State University, Long Beach, Long Beach, CA 90840-1001, USA. jen-mei.chang@csulb.edu.ORCID http://orcid.org/0000-0003-3447-3212
Hui ZengDepartment of Mathematics and Statistics, California State University, Long Beach, Long Beach, CA 90840-1001, USA.
Ruxu HanDepartment of Mathematics and Statistics, California State University, Long Beach, Long Beach, CA 90840-1001, USA.
Ya-Mei ChangDepartment of Statistics, Tamkang University, No.151, Yingzhuan Rd., New Taipei City, 25137, Taiwan.
Ruchit ShahPlacental Analytics, LLC, New Rochelle, NY, USA.
Carolyn M SalafiaPlacental Analytics, LLC, New Rochelle, NY, USA.
Craig NewschafferDrexel University, Philadelphia, PA, USA.
Richard K MillerNIH National Children's Study Placenta Consortium, Bethesda, MD, USA.
Philip KatzmanNIH National Children's Study Placenta Consortium, Bethesda, MD, USA.
Jack MoyeNICHD, Bethesda, MD, USA.
Margaret FallinJohns Hopkins University, Baltimore, MD, USA.
Cheryl K WalkerNIH National Children's Study Placenta Consortium, Bethesda, MD, USA.
Lisa CroenNIH National Children's Study Placenta Consortium, Bethesda, MD, USA.

Funding

National Institutes of Health NCS-BIO-2-18
6 · The paper itself

Abstract

backgroundAutism Spectrum Disorder (ASD) is one of the fastest-growing developmental disorders in the United States. It was hypothesized that variations in the placental chorionic surface vascular network (PCSVN) structure may reflect both the overall effects of genetic and environmentally regulated variations in branching morphogenesis within the conceptus and the fetus' vital organs. This paper provides sound evidences to support the study of ASD risks with PCSVN through a combination of feature-selection and classification algorithms.

methodsTwenty eight arterial and 8 shape-based PCSVN attributes from a high-risk ASD cohort of 89 placentas and a population-based cohort of 201 placentas were examined for ranked relevance using a modified version of the random forest algorithm, called the Boruta method. Principal component analysis (PCA) was applied to isolate principal effects of arterial growth on the fetal surface of the placenta. Linear discriminant analysis (LDA) with a 10-fold cross validation was performed to establish error statistics.

resultsThe Boruta method selected 15 arterial attributes as relevant, implying the difference in high and low ASD risk can be explained by the arterial features alone. The five principal features obtained through PCA, which accounted for about 88% of the data variability, indicated that PCSVNs associated with placentas of high-risk ASD pregnancies generally had fewer branch points, thicker and less tortuous arteries, better extension to the surface boundary, and smaller branch angles than their population-based counterparts.

conclusionWe developed a set of methods to explain major PCSVN differences between placentas associated with high risk ASD pregnancies and those selected from the general population. The research paradigm presented can be generalized to study connections between PCSVN features and other maternal and fetal outcomes such as gestational diabetes and hypertension.

Indexed as

Risk AssessmentAdultAlgorithmsAutism Spectrum DisorderChorionic VilliCohort StudiesFemaleHumansInfant, NewbornPlacentaPregnancyPrincipal Component AnalysisArterial networkAutism spectrum disorder riskBoruta algorithmLinear discriminant analysisPlacentaPlacental chorionic surface vascular network (PCSVN)Principal component analysisRandom forest

Identifiers

PMID29212472
PMCPMC5719902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.